文献速递关节外科骨质疏松与代谢性骨病

改良Kerboul角预测髓芯减压联合或不联合细胞治疗的结果

Modified Kerboul Angle Predicts Outcome of Core Decompression With or Without Additional Cell Therapy.
PubMed 文献 · J Arthroplasty · 2021-02-02

本研究回顾性分析了66例(83髋)早期股骨头坏死(ONFH,ARCO I-IIIa期)患者,接受单纯髓芯减压或联合骨髓浓缩物(BMAC)治疗。平均随访36±23个月,联合BMAC组塌陷率和全髋关节置换(THA)转化率显著低于单纯减压组。改良Kerboul角<250°时联合BMAC效果更可靠,>250°时失败率高。

要点

  • 联合BMAC可降低早期ONFH塌陷率和THA转化率。
  • 改良Kerboul角<250°时联合BMAC获益明显。
  • 改良Kerboul角>250°时无论是否联合BMAC失败率均高。

核心结论

  • 对于改良Kerboul角>250°的早期ONFH,髓芯减压联合或不联合BMAC失败率均高,疾病进展和THA需求增加。
  • 对于塌陷前ONFH且改良Kerboul角<250°的患者,联合BMAC比单纯髓芯减压结果更可靠。

研究设计与样本

  • 回顾性 review 了66例(83髋)早期ONFH患者,ARCO分期I-IIIa期。
  • 单纯髓芯减压组26例(33髋),联合BMAC组40例(50髋)。
  • 采用Kaplan-Meier法分析生存率和进展性塌陷,评估THA转化。
  • 根据改良Kerboul角进行亚组分析:I级(<200°)、II级(200°-249°)、III级(250°-299°)、IV级(≥300°)。

主要发现

  • 平均随访36±23个月。

关键数值与推荐

  • 改良Kerboul角分级:I级<200°,II级200°-249°,III级250°-299°,IV级≥300°。
  • 早期ONFH定义为ARCO分期I-IIIa期。

临床怎么用

  • 对于早期ONFH且改良Kerboul角<250°的患者,可考虑髓芯减压联合BMAC以降低塌陷和THA风险。
  • 对于改良Kerboul角>250°的患者,髓芯减压联合或不联合BMAC失败率均高,需谨慎选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Core decompression is the most common procedure for early-stage osteonecrosis of the femoral head (ONFH). This study investigated outcomes of core decompression with/without bone marrow aspirate concentrate (BMAC), based on the Kerboul combined necrotic angles using magnetic resonance imaging. METHODS: We reviewed 66 patients (83 hips) with early ONFH, Association Research Circulation Osseous stages I-IIIa, who underwent core decompression alone (26 patients, 33 hips) or in combination with BMAC (40 patients, 50 hips). Survival rate and progressive collapse were analyzed using the Kaplan-Meier method, and conversion to total hip arthroplasty (THA) was evaluated. Subgroup analyses based on the modified Kerboul angle were performed: grade I (<200°), grade II (200°-249°), grade III (250°-299°), and grade IV (≥300°). RESULTS: Mean follow-up was 36 ± 23 months. Femoral head collapse with BMAC (16 hips, 32%) was significantly lower than without BMAC (19 hips, 58%, P = .019). Conversion THA was significantly lower with BMAC (28%) than without (58%, P = .007). Survival rates among groups showed significant differences (P = .017). In grade I, 0/12 hips with BMAC collapsed while 3/9 (33%) without BMAC collapsed (P = .063); in grade II, 2/16 hips (12%) with BMAC collapsed while 7/13 (54%) without BMAC collapsed (P = .023). There was no significant difference in collapse with (64%) or without (82%) BMAC in grade III-IV hips (P = .256). CONCLUSION: Core decompression with/without BMAC had a high failure rate, by increasing disease progression and the necessity for THA, for combined necrotic angles >250°. In our study, addition of BMAC had more reliable outcomes than isolated core decompression for precollapse ONFH if the combined necrotic angles were <250°.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Boontanapibul K, Huddleston JI, Amanatullah DF, et al. Modified Kerboul Angle Predicts Outcome of Core Decompression With or Without Additional Cell Therapy. J Arthroplasty. 2021. PMID: 33618954. doi:10.1016/j.arth.2021.01.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。